Triumph Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Buy |
18,102
+9,466
| +110% | +$229K | 0.13% | 179 |
|
|
2025
Q1 | $219K | Sell |
8,636
-1,647
| -16% | -$41.7K | 0.07% | 254 |
|
|
2024
Q4 | $273K | Buy |
10,283
+1,717
| +20% | +$45.6K | 0.09% | 227 |
|
|
2024
Q3 | $248K | Sell |
8,566
-37,402
| -81% | -$1.08M | 0.09% | 234 |
|
|
2024
Q2 | $1.29M | Buy |
45,968
+18,161
| +65% | +$508K | 0.5% | 44 |
|
|
2024
Q1 | $771K | Buy |
27,807
+2,987
| +12% | +$82.8K | 0.31% | 79 |
|
|
2023
Q4 | $715K | Buy |
24,820
+9,744
| +65% | +$281K | 0.3% | 74 |
|
|
2023
Q3 | $500K | Buy |
15,076
+946
| +7% | +$31.4K | 0.23% | 101 |
|
|
2023
Q2 | $518K | Buy |
14,130
+2,572
| +22% | +$94.3K | 0.23% | 93 |
|
|
2023
Q1 | $472K | Sell |
11,558
-9,450
| -45% | -$386K | 0.24% | 80 |
|
|
2022
Q4 | $1.08M | Buy |
21,008
+8,438
| +67% | +$432K | 0.58% | 36 |
|
|
2022
Q3 | $550K | Buy |
12,570
+7,226
| +135% | +$316K | 0.3% | 79 |
|
|
2022
Q2 | $280K | Sell |
5,344
-1,497
| -22% | -$78.4K | 0.15% | 150 |
|
|
2022
Q1 | $354K | Buy |
+6,841
| New | +$354K | 0.15% | 136 |
|